1-10 of 10
Miranda Chapman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetic Profile of Nonacog Gamma (recombinant factor IX) in Previously-Treated Patients with Severe or Moderately Severe Hemophilia B

Jerzy Windyga, MD, Toshko Jelev Lissitchkov, MD, Miranda Chapman, Srilatha D. Tangada, PhD, Nirjhar Chatterjee, MD
Journal: Blood
Blood (2016) 128 (22): 4978.
DOI: https://doi.org/10.1182/blood.V128.22.4978.4978
Published: 2016
Journal Articles

Recombinant Factor IX in Surgical Management of Hemostasis in Hemophilia B Patients: A Prospective Clinical Trial

Jerzy Windyga, MD, Toshko Jelev Lissitchkov, MD, Vasily Mamonov, MD, Miranda Chapman, Srilatha D. Tangada, PhD, Brigitt E. Abbuehl, MD
Journal: Blood
Blood (2016) 128 (22): 2585.
DOI: https://doi.org/10.1182/blood.V128.22.2585.2585
Published: 2016
Journal Articles

Pharmacokinetics of a Recombinant Von Willebrand Factor in Patients with Severe Von Willebrand Disease

Margaret V Ragni, Giancarlo Castaman, Joan Cox Gill, Peter Kouides, Miranda Chapman, Arthur Sytkowski, Ortrun Obermann-Slupetzky, Isabella Presch, Sandor Fritsch, Bruce M. Ewenstein
Journal: Blood
Blood (2015) 126 (23): 2293.
DOI: https://doi.org/10.1182/blood.V126.23.2293.2293
Published: 2015
Journal Articles

Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease

Clinical Trials & Observations
Joan C. Gill, Giancarlo Castaman, Jerzy Windyga, Peter Kouides, Margaret Ragni, Frank W. G. Leebeek, Ortrun Obermann-Slupetzky, Miranda Chapman, Sandor Fritsch, Borislava G. Pavlova, Isabella Presch, Bruce Ewenstein
Journal: Blood
Blood (2015) 126 (17): 2038–2046.
DOI: https://doi.org/10.1182/blood-2015-02-629873
Published: 2015
Journal Articles

Recombinant Factor VIII Combined With Recombinant Von Willebrand Factor In Patients With Severe Hemophilia A: A Prospective Clinical Study Of Safety and Pharmacokinetics

Toshko Lissitchkov, Jerzy Windyga, Barbara A. Konkle, Wolfgang Draxler, Miranda Chapman, Wing-Yen Wong, Benny Sørensen, Bruce M. Ewenstein
Journal: Blood
Blood (2013) 122 (21): 336.
DOI: https://doi.org/10.1182/blood.V122.21.336.336
Published: 2013
Journal Articles

Pharmacokinetics, Efficacy and Safety Of a Recombinant Factor IX (BAX326) In Previously-Treated Pediatric Patients < 12 Years Of Age With Severe Or Moderately Severe Hemophilia B

Tomasz Urasinski, Oleksandra Stasyshyn, Tatiana Andreeva, Luminita Rusen, Farida Perina, MyungShin Oh, Miranda Chapman, Borislava G Pavlova, Wing Yen Wong, Brigitt E. Abbuehl
Journal: Blood
Blood (2013) 122 (21): 1118.
DOI: https://doi.org/10.1182/blood.V122.21.1118.1118
Published: 2013
Journal Articles

Treatment Of Serious Bleeds With a B-Domain Deleted Recombinant Porcine Sequence Factor VIII (OBI-1) In Patients With Acquired Hemophilia A: A Prospective Clinical Trial

Rebecca Kruse-Jarres, MD, MPH, Jean St. Louis, MD, Anne Greist, MD, Amy D. Shapiro, MD, Hedy Smith, MD PhD, Pratima Chowdary, MBBS, FRCP, FRCPath, Anja B Drebes, MRCP, FRCPath, Edward D. Gomperts, MD, Miranda Chapman, Min Mo, Aaron Novack, PhD, Heinrich D. Farin, MD
Journal: Blood
Blood (2013) 122 (21): 206.
DOI: https://doi.org/10.1182/blood.V122.21.206.206
Published: 2013
Journal Articles

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

Clinical Trials & Observations
Pier Mannuccio Mannucci, Christine Kempton, Carolyn Millar, Edward Romond, Amy Shapiro, Ingvild Birschmann, Margaret V. Ragni, Joan Cox Gill, Thynn Thynn Yee, Robert Klamroth, Wing-Yen Wong, Miranda Chapman, Werner Engl, Peter L. Turecek, Tobias M. Suiter, Bruce M. Ewenstein
Journal: Blood
Blood (2013) 122 (5): 648–657.
DOI: https://doi.org/10.1182/blood-2013-01-479527
Published: 2013
Includes: Supplemental data
Journal Articles

Pharmacokinetics, Efficacy and Safety of BAX326, a Novel Recombinant Factor IX: A Prospective, Controlled, Multicenter Study in Previously Treated Patients with Severe (FIX Level < 1%) or Moderately Severe (FIX Level ≤ 2%) Hemophilia B.

Jerzy Windyga, MD, PhD, Toshko Lissitchkov, MD, PhD, Oleksandra Stasyshyn, MD, Vasily Mamonov, MD, Luminita Rusen, MD, PhD, José Luis Lamas, MD, Myungshin Oh, PhD, Miranda Chapman, Sandor Fritsch, PhD, Borislava G Pavlova, PhD, Wing Yen Wong, MD, Brigitt E. Abbuehl, MD
Journal: Blood
Blood (2012) 120 (21): 2222.
DOI: https://doi.org/10.1182/blood.V120.21.2222.2222
Published: 2012
Journal Articles

Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

Tobias M Suiter, MD, Pier Mannuccio Mannucci, MD, Christine L Kempton, MD, MSc, Michael Laffan, MD, Edward H Romond, MD, Amy D. Shapiro, MD, Ingvild Birschmann, MD, PhD, Margaret V. Ragni, MD, MPH, Joan Cox Gill, MD, Thynn Thynn Yee, MD, MSc, FRCP, Robert Klamroth, MD, PhD, Frank M Horling, PhD, Birgit M Reipert, PhD, Peter L Turecek, PhD, Katalin Varadi, PhD, Miranda Chapman, Werner Engl, PhD, Wing Yen Wong, MD, Bruce M. Ewenstein, MD PhD, rhVWF Study Team
Journal: Blood
Blood (2011) 118 (21): 2275.
DOI: https://doi.org/10.1182/blood.V118.21.2275.2275
Published: 2011